News
News
Healthtech
Pharma
Hospitals & Providers
Diagnostics
Medical Devices
Policy & Public Health
Finance
Precision Medicine
Global
Podcast
Insights
VOH Exclusives
VOH Exclusives
Brands in Focus
Idea Leader
Listicles
Editorials
VOH TV
VOH TV
Expert Speaks
The Big Idea
Daily Broadcast
Events
Events
Health Awareness
Conferences & Summits
Brand Solutions
Gene Editing Therapies
Precision Medicine
Eli Lilly to Acquire Verve Therapeutics in $1.3 Billion Deal to Advance Gene Editing Therapies for Cardiovascular Disease
Edited By VOH
18 Jun 2025
2 min read
Voice Of HealthCare
vohnetwork.com
INSTALL APP
